HMOX1 and metabolic disease: Recent studies utilizing gene knockdown techniques and small molecule inhibitors have shown that HO-1 induction suppresses development of metabolic disorders and nerve system disorders including obesity [8], hypertension [9], atherosclerosis [10], Parkinson’s disease [11] and hepatic fibrosis [12].